華上生醫
| 年度/季度 | 總資產 | 總負債 | 股東權益(淨值) |
|---|
| 2025Q4 | 526,752 | 23,770 | 502,982 |
| 2025Q2 | 587,173 | 23,315 | 563,858 |
| 2024Q4 | 662,600 | 29,277 | 633,323 |
| 2024Q2 | 700,763 | 29,880 | 670,883 |
| 2023Q4 | 561,250 | 26,813 | 534,437 |
| 2023Q2 | 600,531 | 45,133 | 555,398 |
| 2022Q4 | 288,705 | 12,047 | 276,658 |
| 2022Q2 | 130,489 | 28,395 | 102,094 |
| 2021Q4 | 157,173 | 21,607 | 135,566 |
| 2021Q2 | 173,233 | 4,761 | 168,472 |
| 年度/季度 | 流動資產 | 長期投資 | 固定資產 | 其餘資產 | 總資產 |
|---|
| 2025Q4 | 466,451 | | 2,919 | 57,382 | 526,752 |
| 2025Q2 | 525,549 | | 3,226 | 58,398 | 587,173 |
| 2024Q4 | 598,697 | | 3,797 | 60,106 | 662,600 |
| 2024Q2 | 627,402 | | 4,264 | 69,097 | 700,763 |
| 2023Q4 | 485,454 | | 2,778 | 73,018 | 561,250 |
| 2023Q2 | 530,771 | | 143 | 69,617 | 600,531 |
| 2022Q4 | 251,454 | | 116 | 37,135 | 288,705 |
| 2022Q2 | 94,771 | | 95 | 35,623 | 130,489 |
| 2021Q4 | 125,405 | | 118 | 31,650 | 157,173 |
| 2021Q2 | 159,084 | | 445 | 13,704 | 173,233 |
| 年度/季度 | 流動負債 | 非流動負債 | 總負債 |
|---|
| 2025Q4 | 19,337 | 4,433 | 23,770 |
| 2025Q2 | 17,336 | 5,979 | 23,315 |
| 2024Q4 | 21,823 | 7,454 | 29,277 |
| 2024Q2 | 20,971 | 8,909 | 29,880 |
| 2023Q4 | 15,932 | 10,881 | 26,813 |
| 2023Q2 | 32,890 | 12,243 | 45,133 |
| 2022Q4 | 12,047 | | 12,047 |
| 2022Q2 | 28,395 | | 28,395 |
| 2021Q4 | 21,607 | | 21,607 |
| 2021Q2 | 4,761 | 0 | 4,761 |
| 年度/季度 | 股本 | 股東權益(淨值) |
|---|
| 2025Q4 | 437,062 | 502,982 |
| 2025Q2 | 436,437 | 563,858 |
| 2024Q4 | 436,437 | 633,323 |
| 2024Q2 | 434,870 | 670,883 |
| 2023Q4 | 383,575 | 534,437 |
| 2023Q2 | 382,300 | 555,398 |
| 2022Q4 | 292,865 | 276,658 |
| 2022Q2 | 225,750 | 102,094 |
| 2021Q4 | 225,750 | 135,566 |
| 2021Q2 | 225,750 | 168,472 |